05/02/2024 5:01 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 3:19 PM | Nurix Therapeutics (Subject) van Houte Hans (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024 5:33 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 5:33 PM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 5:33 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/12/2024 4:10 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
04/12/2024 4:12 PM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
04/11/2024 3:06 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
04/10/2024 6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 6:06 AM | Nurix Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/09/2024 12:17 PM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/27/2024 6:01 AM | Nurix Therapeutics (Filer)
| Form DEF 14A | |
03/27/2024 6:02 AM | Nurix Therapeutics (Filer)
| Form DEFA14A | |
03/27/2024 6:03 AM | Nurix Therapeutics (Filer)
| Form ARS | |
03/11/2024 6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 6:20 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:22 PM | Nurix Therapeutics (Subject) van Houte Hans (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024 3:51 PM | Nurix Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/15/2024 6:22 AM | Nurix Therapeutics (Issuer) SANDS ARTHUR T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 6:23 AM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 6:23 AM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 6:23 AM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:51 AM | Deep Track Capital, LP (Filed by) Nurix Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 7:00 AM | Nurix Therapeutics (Subject) SANDS ARTHUR T (Filed by)
| Form SC 13G | |
02/09/2024 12:47 PM | MORGAN STANLEY (Filed by) Nurix Therapeutics (Subject)
| Form SC 13G | |
02/09/2024 12:56 PM | Nurix Therapeutics (Subject) WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
01/30/2024 5:52 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 5:52 PM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 5:53 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 3:00 PM | ARK Investment Management LLC (Filed by) Nurix Therapeutics (Subject)
| Form SC 13G | |
01/24/2024 1:27 PM | BlackRock Inc. (Filed by) Nurix Therapeutics (Subject)
| Form SC 13G/A | |
01/23/2024 9:28 AM | Nurix Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/08/2024 6:03 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/21/2023 4:19 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:55 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 11:03 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 6:01 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2023 3:40 PM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2023 3:40 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2023 3:41 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 3:03 PM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Biggest hedge fund manager has huge warning for U.S. dollar (Ad) Prescient CEO Makes Shocking New Prediction
Known for his eerily accurate market calls over the years, this CEO has just revealed his newest prediction about "America's New Money." Get the details before it's taken offline. |
10/12/2023 3:06 PM | Nurix Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/07/2023 6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2023 3:26 PM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2023 3:27 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2023 3:28 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/13/2023 3:18 PM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/13/2023 3:19 PM | Nurix Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |